Clinical trial
A Comparative Study To Determine If Motivating Asthma Education (Compliance…
NCT00351143 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00351143 |
|---|---|
| Title | A Comparative Study To Determine If Motivating Asthma Education (Compliance Enhancement) Has An Effect On Asthma Control |
| Official title | A Randomized, Open Label Comparative Study to Determine the Proportion of Asthma Patients on SERETIDE Diskus 50/250 mcg b.i.d. Achieving Total Control When Given Medication and Compliance Enhancement Training Compared to Those Receiving Medication Only |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | salmeterol/fluticasone propionate 50/250 µg + 3 training sessions of compliance enhancement training, salmeterol/fluticasone propionate 50/250 µg |
| Enrollment | 274 |
| Start date | Jul 26, 2005 |
| Primary completion | Jun 13, 2007 |
| Completion | Jun 13, 2007 |
| First posted | Jul 12, 2006 |
| Last update posted | Sep 11, 2017 |
| Countries | Denmark, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: